Ma, Hong
Marti-Gutierrez, Nuria
Park, Sang-Wook
Wu, Jun
Lee, Yeonmi
Suzuki, Keiichiro
Koski, Amy
Ji, Dongmei
Hayama, Tomonari
Ahmed, Riffat
Darby, Hayley
Van Dyken, Crystal
Li, Ying
Kang, Eunju
Park, A.-Reum
Kim, Daesik
Kim, Sang-Tae
Gong, Jianhui
Gu, Ying
Xu, Xun
Battaglia, David
Krieg, Sacha A.
Lee, David M.
Wu, Diana H.
Wolf, Don P.
Heitner, Stephen B.
Belmonte, Juan Carlos Izpisua
Amato, Paula
Kim, Jin-Soo
Kaul, Sanjiv
Mitalipov, Shoukhrat
Article History
Received: 28 March 2017
Accepted: 27 June 2017
First Online: 2 August 2017
Change Date: 2 October 2017
Change Type: Update
Change Details: Editorial Note: Readers are alerted that some of the conclusions of this paper are subject to critiques that are being considered by editors. Some of these critiques have been publicly deposited in preprint form. A further editorial response will follow the resolution of these issues.
Competing interests
: J.-S.K. is a co-founder and shareholder of ToolGen, Inc, and S.M. is a co-founder and shareholder of Mitogenome Therapeutics, Inc and Health and Science Center “M1” Inc and declare competing financial interests. The other authors declare no competing financial interests.